XPD 312 single nucleotide polymorphism (SNP) predicts survival in stage IIIA-B non-sinall-cell lung cancer (NSCLC) patients (pts) < 59 years (y) treated with chemotherapy followed by surgery

1. Santarpia, C.
2. Garrido, P.
3. Gonzalez-Larriba, J. L.
4. Azagra, R.
5. Cardenal, F.
6. Ramirez, J. L.
7. De Aguirre, I.
8. Sanchez-Ronco, M.
9. Taron, M.
10. Rosell, R.